The abstract is read at the publisher; the summary is JClub's.
Antibody display technologies have evolved since phage display’s 1985 introduction, expanding protein–nucleic acid linkage to support new modalities and larger, faster functional discovery.
- Why it matters: The field needs experimental platforms that connect protein function to sequence while keeping pace with emerging antibody formats and the scale required for drug discovery.
- What they did: The review traces multiple branches of protein display, highlighting recent advances that expand library size, speed functional discovery, and integrate computational analysis with structural predictions.
- The result: These developments enable broader applications across antibody drug discovery, immunology, and biotechnology, leveraging experimental data to guide functional identification.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.